| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30001788 | HIV | ENSG00000148680.16 | protein_coding | HTR7 | No | No | 3363 | P34969 |
| TVIS30081632 | HIV | ENSG00000148680.16 | protein_coding | HTR7 | No | No | 3363 | P34969 |
| TVIS20006328 | HPV | ENSG00000148680.16 | protein_coding | HTR7 | No | No | 3363 | P34969 |
| TVIS20033320 | HPV | ENSG00000148680.16 | protein_coding | HTR7 | No | No | 3363 | P34969 |
| TVIS20048781 | HPV | ENSG00000148680.16 | protein_coding | HTR7 | No | No | 3363 | P34969 |
| TVIS20036895 | HPV | ENSG00000148680.16 | protein_coding | HTR7 | No | No | 3363 | P34969 |
| TVIS20041222 | HPV | ENSG00000148680.16 | protein_coding | HTR7 | No | No | 3363 | P34969 |
| TVIS44004709 | HTLV-1 | ENSG00000148680.16 | protein_coding | HTR7 | No | No | 3363 | P34969 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | HTR7 |
|---|---|
| DrugBank ID | DB00988 |
| Drug Name | Dopamine |
| Target ID | BE0000650 |
| UniProt ID | P34969 |
| Regulation Type | binder |
| PubMed IDs | 8398139; 8394362 |
| Citations | Lovenberg TW, Baron BM, de Lecea L, Miller JD, Prosser RA, Rea MA, Foye PE, Racke M, Slone AL, Siegel BW, et al.: A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron. 1993 Sep;11(3):449-58.@@Shen Y, Monsma FJ Jr, Metcalf MA, Jose PA, Hamblin MW, Sibley DR: Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J Biol Chem. 1993 Aug 25;268(24):18200-4. |
| Groups | Approved |
| Direct Classification | Catecholamines and derivatives |
| SMILES | NCCC1=CC(O)=C(O)C=C1 |
| Pathways | Remifentanil Action Pathway; Hydrocodone Action Pathway; Sufentanil Action Pathway; Morphine Action Pathway; Fluoxetine Action Pathway; 3-Methylthiofentanyl Action Pathway; Benzocaine Action Pathway; Oxybuprocaine Action Pathway; Codeine Action Pathway; Alkaptonuria; Tyrosine Hydroxylase Deficiency; Ketobemidone Action Pathway; Propoxyphene Action Pathway; Dihydromorphine Action Pathway; Nicotine Action Pathway; Proparacaine Action Pathway; Methadyl Acetate Action Pathway; Hawkinsinuria; Oxymorphone Action Pathway; Fentanyl Action Pathway; Dimethylthiambutene Action Pathway; Dopamine beta-Hydroxylase Deficiency; Lidocaine (Local Anaesthetic) Action Pathway; Monoamine Oxidase-A Deficiency (MAO-A); Aromatic L-Aminoacid Decarboxylase Deficiency; Hydromorphone Action Pathway; Tyrosinemia, Transient, of the Newborn; Anileridine Action Pathway; Bupivacaine Action Pathway; Dopamine Activation of Neurological Reward System |
| PharmGKB | PA449396 |
| ChEMBL | CHEMBL59 |
